首页 > 抗体 > 一抗 > 其它 > CLN8 Polyclonal Antibody
CLN8 Polyclonal Antibody
商品货号: PLA008289
适 应 性: 人,大鼠,小鼠,
WB ELISA
¥600元
规格:
在线咨询
MSDS
说明书
商品描述
  • 基因名称: CLN8 C8orf61
  • 蛋白名称: Protein CLN8
  • Human_gene_id: 2055
  • Human_swiss_prot_no: Q9UBY8
  • Human_swiss_link: https://www.uniprot.org/uniprotkb/Q9UBY8/entry
  • Mouse_swiss_prot_no: Q9QUK3
  • Mouse_swiss_link: http://www.uniprot.org/uniprot/Q9QUK3
  • Rat_swiss_prot_no: Q6AYM9
  • Rat_swiss_link: http://www.uniprot.org/uniprot/O54941Q6AYM9
  • 特异性: CLN8 Polyclonal Antibody detects endogenous levels of protein.
  • 组成: Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
  • 来源: Polyclonal, Rabbit,IgG
  • 稀释: WB 1:500-2000 ELISA 1:5000-20000
  • 纯化工艺: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • 浓度: 1 mg/ml
  • 储存: -15°C to -25°C/1 year(Do not lower than -25°C)
  • 说明书: 1
  • Msds: MSDS_Antibody.pdf
  • 实测条带: 31kD
  • 功能: disease:Defects in CLN8 are the cause of neuronal ceroid lipofuscinosis 8 (CLN8) [MIM:600143]. Childhood-onset neuronal ceroid lipofuscinoses (NCL) are a group of autosomal recessive progressive encephalopathies characterized by the accumulation of autofluorescent material, mainly ATP synthase subunit C, in various tissues, notably in neurons. Based on clinical features, the country of origin of patients, and the molecular genetic background of the disorder, at least seven different forms are thought to exist. CLN8 is characterized by normal early development, onset of generalized seizures between 5 and 10 years, and subsequent progressive mental retardation.,disease:Defects in CLN8 are the cause of progressive epilepsy with mental retardation (EPMR) [MIM:610003]; also called Northern epilepsy variant of neuronal ceroid lipofuscinosis 8. EPMR is a form of NCL so far described only in Finland. It has been considered as a distinct clinical and genetic entity among the NCL.,online information:Neural Ceroid Lipofuscinoses mutation db,PTM:Does not seem to be N-glycosylated.,similarity:Contains 1 TLC (TRAM/LAG1/CLN8) domain.,
  • 相关产品: RS0001,RS0002,YM3028,YM3029
  • 细胞定位: Endoplasmic reticulum membrane ; Multi-pass membrane protein . Endoplasmic reticulum-Golgi intermediate compartment membrane ; Multi-pass membrane protein . Endoplasmic reticulum .
  • 组织表达: Placenta,Uterus,
  • 科研货号: PLA008289
CLN8 Polyclonal Antibody
Catalog No PLA008289
Product information
  • 基因名称: CLN8 C8orf61
  • 蛋白名称: Protein CLN8
  • Human_gene_id: 2055
  • Human_swiss_prot_no: Q9UBY8
  • Human_swiss_link: https://www.uniprot.org/uniprotkb/Q9UBY8/entry
  • Mouse_swiss_prot_no: Q9QUK3
  • Mouse_swiss_link: http://www.uniprot.org/uniprot/Q9QUK3
  • Rat_swiss_prot_no: Q6AYM9
  • Rat_swiss_link: http://www.uniprot.org/uniprot/O54941Q6AYM9
  • 特异性: CLN8 Polyclonal Antibody detects endogenous levels of protein.
  • 组成: Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
  • 来源: Polyclonal, Rabbit,IgG
  • 稀释: WB 1:500-2000 ELISA 1:5000-20000
  • 纯化工艺: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • 浓度: 1 mg/ml
  • 储存: -15°C to -25°C/1 year(Do not lower than -25°C)
  • 说明书: 1
  • Msds: MSDS_Antibody.pdf
  • 实测条带: 31kD
  • 功能: disease:Defects in CLN8 are the cause of neuronal ceroid lipofuscinosis 8 (CLN8) [MIM:600143]. Childhood-onset neuronal ceroid lipofuscinoses (NCL) are a group of autosomal recessive progressive encephalopathies characterized by the accumulation of autofluorescent material, mainly ATP synthase subunit C, in various tissues, notably in neurons. Based on clinical features, the country of origin of patients, and the molecular genetic background of the disorder, at least seven different forms are thought to exist. CLN8 is characterized by normal early development, onset of generalized seizures between 5 and 10 years, and subsequent progressive mental retardation.,disease:Defects in CLN8 are the cause of progressive epilepsy with mental retardation (EPMR) [MIM:610003]; also called Northern epilepsy variant of neuronal ceroid lipofuscinosis 8. EPMR is a form of NCL so far described only in Finland. It has been considered as a distinct clinical and genetic entity among the NCL.,online information:Neural Ceroid Lipofuscinoses mutation db,PTM:Does not seem to be N-glycosylated.,similarity:Contains 1 TLC (TRAM/LAG1/CLN8) domain.,
  • 相关产品: RS0001,RS0002,YM3028,YM3029
  • 细胞定位: Endoplasmic reticulum membrane ; Multi-pass membrane protein . Endoplasmic reticulum-Golgi intermediate compartment membrane ; Multi-pass membrane protein . Endoplasmic reticulum .
  • 组织表达: Placenta,Uterus,
  • 科研货号: PLA008289
  • Hunan UPT Biotechnology Co.,Ltd
    Website:www.uptbio.com Servive hotline :4006916686
    E-mail:service@uptbio.com
    Address:
    Room 402, Building 13, Xinggong International Industrial Park, 100 Guyuan Road, Yuelu District, Changsha City, Hunan Province, China.
普拉特泽实验室电话助手

4006916686

扫码咨询